Antigen-specific immune responses through 24 months in the STAND trial: A randomized phase 2 study evaluating optimal sequencing of sipuleucel-T (spin-T) and androgen deprivation therapy (ADT) in biochemically-recurrent prostate cancer (BRPC)
Meeting Abstract
Antonarakis, Emmanuel S.; Kibel, Adam S.; Adams, George W.; Karsh, Lawrence Ivan; Elflicy, Aymen; Shore, Neal D.; Vogelzang, Nicholas J.; Corman, John M.; Tyler, Robert Claude; McCoy, Candice; Devries, Todd; Sheikh, Nadeem A.; Drake, Charles G.